Notable Frances Benson 12/13/22 Notable Frances Benson 12/13/22

Nimbus Therapeutics TYK2 program to be acquired by Takeda for $4B in upfront cash and up to $2B in potential commercial milestone payments

Read More

Notable Frances Benson 12/9/22 Notable Frances Benson 12/9/22

Arcellx announces strategic collaboration with Kite, a Gilead Company, to co-develop and co- commercialize late- stage clinical CART-ddBCMA in multiple myeloma

Read More

Financing and Partnerships Frances Benson 12/6/22 Financing and Partnerships Frances Benson 12/6/22

HotSpot Therapeutics launches strategic collaboration with AbbVie to further expand immunology pipeline

Read More

Clinical Impact Frances Benson 11/30/22 Clinical Impact Frances Benson 11/30/22

Nimbus Therapeutics announces positive topline results for Ph2b clinical trial of allosteric TYK2 inhibitor

Read More

New investments Frances Benson 11/17/22 New investments Frances Benson 11/17/22

Rezo Therapeutics, founded by renowned UCSF scientists, raises $78M in Series A

Read More

Financing and Partnerships Frances Benson 11/8/22 Financing and Partnerships Frances Benson 11/8/22

ARS Pharmaceuticals closes merger with Silverback Therapeutics and currently has over $280M in cash

Read More

People Frances Benson 10/26/22 People Frances Benson 10/26/22

Nimbus Therapeutics appoints Nathalie Franchimont as CMO

Read More

Clinical Impact Frances Benson 10/21/22 Clinical Impact Frances Benson 10/21/22

ARS Pharmaceuticals announces FDA acceptance of NDA for neffy® (epinephrine nasal spray) for the treatment of allergic reactions (type I) including anaphylaxis

Read More

Financing and Partnerships Frances Benson 10/13/22 Financing and Partnerships Frances Benson 10/13/22

Odyssey Therapeutics raises $168M in Series B

Read More

Financing and Partnerships Frances Benson 10/11/22 Financing and Partnerships Frances Benson 10/11/22

Nimbus Therapeutics announces research collaboration and license agreement with Lilly

Read More

People Frances Benson 9/28/22 People Frances Benson 9/28/22

ADARx Pharmaceuticals appoints Christopher Prentiss as CFO

Read More

Financing and Partnerships Frances Benson 9/12/22 Financing and Partnerships Frances Benson 9/12/22

Nimbus Therapeutics closes $125M in private financing

Read More

People Frances Benson 8/16/22 People Frances Benson 8/16/22

Simcha Theraeputics accelerates growth with key leadership appointments, expanded research and option agreement with Yale School of Medicine

Read More

People Frances Benson 8/11/22 People Frances Benson 8/11/22

PsiOxus Therapetuics appoints Howard Davis as CEO

Read More

Notable Frances Benson 8/4/22 Notable Frances Benson 8/4/22

MiroBio to be acquired by Gilead Sciences for $405M

Read More

People Frances Benson 7/25/22 People Frances Benson 7/25/22

HotSpot Therapeutics appoints Paul Thibodeau as CBO

Read More

Financing and Partnerships Frances Benson 7/21/22 Financing and Partnerships Frances Benson 7/21/22

ARS Pharmaceuticals and Silverback Therapeutics announces merger

Read More

People Frances Benson 7/19/22 People Frances Benson 7/19/22

HotSpot Therapeutics appoints Jose Carmona to Board of Directors

Read More

Notable Frances Benson 7/5/22 Notable Frances Benson 7/5/22

Ancora Biotech lead clinical asset, TeneoTwo, to be acquired by AstraZeneca for up to $1.27B

Read More

Financing and Partnerships Frances Benson 6/29/22 Financing and Partnerships Frances Benson 6/29/22

MiroBio raises $97M in Series B

Read More